CMR Surgical Hires Industry Leader to Drive Operations in Asia Pacific, Middle East and Africa
- Sushobhan Dasgupta appointed President and Chief Commercial Officer for Asia Pacific, Middle East and Africa
Cambridge, UK – 19 February 2024, 7am GMT. CMR Surgical (CMR or the “Company”), a global surgical robotics business, today announced that Sushobhan Dasgupta has joined the Company as President and Chief Commercial Officer, Asia Pacific, Middle East and Africa.
Mr. Sushovan has over 30 years of global healthcare experience across various medical technology markets worldwide, including 30 years with Johnson & Johnson (J&J). Mr. Sushovan most recently served as Vice Chairman and Global President at Shalvy Limited, a leading Indian healthcare group, where he was primarily responsible for driving Shalvy's acquired orthopedic implants business globally and provided strategic oversight to the underlying hospital business based in California, USA. Prior to that, he had a distinguished career spanning 30 years with Johnson & Johnson MedTech, where he served as a member of the Johnson & Johnson Orthopedics Global Board of Directors and the J&J Asia Pacific MedTech Leadership Team. His last two roles with J&J were Managing Director, J&J Medical India and Vice President, Orthopedics, J&J Asia Pacific.
During his time as Managing Director of J&J Medical India, Sushovan was also the Chairman of NATHEALTH, India's leading healthcare association representing hospitals, medical technology companies, diagnostic companies and other businesses under one platform. He was also awarded the title of Honorary Fellow by the Indian Association of Minimally Invasive Surgeons for his efforts in shaping the healthcare landscape through his work in key industry forums.
Supratim Bose, Chief Executive Officer of CMR Surgical, commented: “Asia Pacific, the Middle East and Africa are the fastest growing markets for surgical robotics in the world, so we are pleased to welcome Sushovan to the CMR team to oversee our sales efforts in these regions. His diverse experience working in various medical technology industry markets and his strong reputation with surgeons and hospitals in the region will be a great asset to our company. With new product launches and strong growth in the region, this is the perfect time for him to join the company and bring the benefits of minimally invasive surgery to more patients.”
“We are pleased to be partnering with NVIDIA to bring our innovative, innovative solutions to the market,” said Sushobhan Dasgupta, president and chief commercial officer, Asia Pacific, Middle East and Africa, CMR Surgical. “Having worked in the medical technology sector in Asia Pacific and the US for over 30 years, I am excited to offer Versius, a truly differentiated product, to hospitals and surgeons. Demand for surgical robotics is strong in Asia Pacific, the Middle East and Africa, and I look forward to working with the CMR team to drive commercial success and most importantly, help patients receive the best surgical care.”
Sushobhan Dasgupta's appointment comes as the company achieves over 50% growth in its global installed base in 2023, completing over 19,000 surgical procedures with Versius.
end
Media Contact:
If you would like to learn more, please contact us at CMR Surgical.
CMR Surgical Press Office
T +44(0) 1223 755801
picture inquiry
Notes to editors:
Versius Surgical Robot System
Versius redefines expectations for robotic surgery. Versius fits into virtually any operating room setup and seamlessly integrates into existing workflows, advancing the possibilities of robotic minimally invasive surgery (MAS). Small, portable and modular, Versius allows surgeons to use only the number of arms needed for a particular procedure.
Mimicking the human arm, Versius gives surgeons the dexterity and precision of small, wrist-worn instruments, plus options to optimize port placement. An open surgeon console with 3D HD vision, easy-to-deploy instrument controls, and ergonomic working posture options reduces stress and fatigue and enables clear communication with the surgical team. Think laparoscopically and operate robotically with Versius, and patients, surgeons, and medical professionals can all benefit from the value that a robotic MAS brings.
But it's more than just a robot. Versius collects meaningful data in a broader digital ecosystem to support surgeons' continuous learning. Through the Versius Connect app, Versius Trainer and the CMR clinical registry, Versius unlocks rich insights to ultimately improve surgical care.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical device company dedicated to transforming surgery with its next-generation surgical robot, Versius.
Headquartered in Cambridge, UK, CMR is committed to working with surgeons, surgical teams and hospital partners to provide the best tools to make robotic minimally invasive surgery accessible and affordable for everyone. At Versius, we are on a mission to redefine the surgical robotics market with actionable, innovative technology and data that can improve surgical care. Founded in 2014, CMR Surgical is a privately owned limited company backed by an international shareholder base.
